Msa - Multiple System Atrophy Clinical Trials
2 recruiting trials for Msa - Multiple System Atrophy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Msa - Multiple System Atrophy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Universitaire Ziekenhuizen KU Leuven (1), Rigshospitalet, Denmark (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is UHR PET/CT scan of the brain with ¹⁸F-FDG (other, 1 trial), followed by UHR PET/CT scan of the brain with ¹⁸F-PE2I, UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1.
Track Msa - Multiple System Atrophy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
The goal of this study is to use ultra-high-resolution (UHR) PET imaging to better understand how the brain and spinal cord change in healthy aging and in neurological and...
Invasive Home Ventilation in Denmark
The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Msa - Multiple System Atrophy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Msa - Multiple System Atrophy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Msa - Multiple System Atrophy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.